Prevalence |
Pre-test probability |
Proportion of population affected by a condition |
Sensitivity |
Detection rate; True positive rate (TPR) |
Proportion of subjects with cancer who test positive |
Specificity |
True negative rate (TNR) |
Proportion of subjects without cancer who test negative |
False positive rate (FPR) |
1 - specificity; Type I Error; α |
Proportion of subjects without cancer who test positive |
False negative rate (FNR) |
1 - sensitivity, Type II error; β |
Proportion of subjects with cancer who test negative |
Positive Predictive Value (PPV) |
Positive post-test probability |
Probability that a subject with a positive test has cancer |
Negative Predictive Value (NPV) |
Negative post-test probability |
Probability that a subject with a negative test does not have cancer |
Positive likelihood ratio (LR+) |
TPR / FPR |
Ratio between the probability of a positive test result given the presence of the disease and the probability of a positive test result given the absence of the disease |
Negative likelihood ratio (LR-) |
1 – TPR / specificity |
Ratio between the probability of a negative test result given the presence of the disease and the probability of a negative test result given the absence of the disease |
Odds Ratio |
[TPR / (1 − TPR)] × [(1 − FPR) / FPR] |
|
Receiver-Operating Characteristic (ROC) Curve |
|
Plot of sensitivity vs. FPR |
Area under the ROC Curve (AUC) |
C-statistic |
A normalized Mann Whitney/Wilcoxon test where the Wilcoxon statistic is divided by the product of the number of individuals in the two groups measured |
Accuracy |
|
Overall probability that a subject will be correctly classified |